A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The ...

People in Phoenix suffering from severe depression now have a Ketamine-derived nasal spray available for treatment.

FDA approves esketamine nasal spray as a standalone treatment for adults with treatment-resistant depression, offering rapid ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

An estimated 21 million American adults suffer from clinical depression. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes ...

The Pinal County Sheriff’s Office announced on Thursday it’s looking for the driver who hit a boy with their car and then drove off in San Tan Valley.

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment ... the treatments work,” Merrill said. “Ketamine is a safe medication when used under ...

( MENAFN - EIN Presswire) Spravato® (esketamine) has been approved for use as a standalone treatment for depression, without the requirement of an accompanying antidepressant. Rachel Norris, MD ...

"This provides further evidence for the use of esketamine nasal spray in this difficult-to-treat ... an intranasal formulation of racemic ketamine. Vertex's gene-editing therapy for sickle cell ...